New drug trial aims to tame severe asthma Flare-Ups
NCT ID NCT06653322
Summary
This study is testing an investigational drug called SHR-1703 for people with a severe type of asthma driven by high levels of white blood cells called eosinophils. It aims to see if the drug can reduce the number of serious asthma attacks (exacerbations) and improve lung function and quality of life over about a year. The trial will involve 400 participants who have had a severe flare-up in the past year and whose asthma is not well-controlled on their current high-dose medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA WITH EOSINOPHILIC PHENOTYPE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West China School of Medicine West China Hospital of Sichuan University
RECRUITINGChengdu, Sichuan, 610041, China
Contact
Conditions
Explore the condition pages connected to this study.